TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer

Transient receptor potential vanilloid type-2 (TRPV2) is an ion channel that is triggered by agonists like cannabidiol (CBD). Triple negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Chemotherapy is still the first line for the treatment of TNBC patients; howev...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Elbaz, Mohamad, Ahirwar, Dinesh, Xiaoli, Zhang, Zhou, Xinyu, Lustberg, Maryam, Nasser, Mohd W., Shilo, Konstantin, Ganju, Ramesh K.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173360/
https://ncbi.nlm.nih.gov/pubmed/30323891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9663
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars